Montag & Caldwell LLC grew its position in Teleflex Incorporated (NYSE:TFX) by 64.3% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,532 shares of the medical technology company’s stock after buying an additional 991 shares during the quarter. Montag & Caldwell LLC’s holdings in Teleflex were worth $679,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently made changes to their positions in the business. State Treasurer State of Michigan boosted its holdings in shares of Teleflex by 1.2% during the first quarter. State Treasurer State of Michigan now owns 16,430 shares of the medical technology company’s stock worth $4,189,000 after purchasing an additional 200 shares during the period. CIBC Asset Management Inc boosted its holdings in shares of Teleflex by 12.9% during the first quarter. CIBC Asset Management Inc now owns 2,172 shares of the medical technology company’s stock worth $554,000 after purchasing an additional 249 shares during the period. Security Asset Management boosted its holdings in shares of Teleflex by 4.2% during the second quarter. Security Asset Management now owns 6,935 shares of the medical technology company’s stock worth $1,860,000 after purchasing an additional 282 shares during the period. Fiduciary Trust Co. boosted its holdings in shares of Teleflex by 21.9% during the first quarter. Fiduciary Trust Co. now owns 1,615 shares of the medical technology company’s stock worth $412,000 after purchasing an additional 290 shares during the period. Finally, Parallel Advisors LLC boosted its holdings in shares of Teleflex by 200.0% during the second quarter. Parallel Advisors LLC now owns 450 shares of the medical technology company’s stock worth $120,000 after purchasing an additional 300 shares during the period. Institutional investors own 89.53% of the company’s stock.
In other news, insider Thomas E. Powell sold 5,200 shares of Teleflex stock in a transaction that occurred on Friday, June 22nd. The shares were sold at an average price of $281.60, for a total value of $1,464,320.00. Following the transaction, the insider now owns 17,083 shares of the company’s stock, valued at $4,810,572.80. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Benson Smith sold 9,331 shares of Teleflex stock in a transaction that occurred on Monday, May 21st. The shares were sold at an average price of $265.26, for a total transaction of $2,475,141.06. Following the completion of the transaction, the director now directly owns 77,887 shares in the company, valued at approximately $20,660,305.62. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 65,602 shares of company stock worth $18,008,816. Insiders own 2.56% of the company’s stock.
Teleflex traded down $21.19, hitting $249.62, during midday trading on Thursday, according to Marketbeat Ratings. 3,752 shares of the company’s stock traded hands, compared to its average volume of 150,453. The firm has a market cap of $12.42 billion, a PE ratio of 29.72, a PEG ratio of 1.92 and a beta of 1.21. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.45 and a current ratio of 2.18. Teleflex Incorporated has a one year low of $197.72 and a one year high of $288.78.
Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 2nd. The medical technology company reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.41 by $0.06. The firm had revenue of $609.87 million for the quarter, compared to analyst estimates of $615.97 million. Teleflex had a net margin of 7.51% and a return on equity of 16.60%. The company’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.04 earnings per share. sell-side analysts anticipate that Teleflex Incorporated will post 9.8 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 14th. Investors of record on Wednesday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 0.54%. Teleflex’s payout ratio is presently 16.19%.
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It offers vascular access products that comprise Arrow branded catheters and related devices, including catheter positioning systems for use in the administration of intravenous medications and other therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site; and devices for treating coronary and peripheral vascular disease.
Featured Article: Market Capitalization
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.